Back

Specification of bone marrow sinusoids requires TIE2-mediated positive feedback involving COUPTFII and VEGFR3

Li, X.; Jia, X.; Sun, Z.; Li, T.; Xu, B.; Cao, X.; Ding, K.; He, Y.

2026-05-20 developmental biology
10.64898/2026.05.17.725724 bioRxiv
Show abstract

The bone marrow (BM) vascular network plays crucial roles in driving bone development and supporting hematopoiesis, yet the mechanisms governing its specialized architecture, particularly sinusoidal morphogenesis, remain inadequately characterized. We show in this study that TIE2 (Tek) was highly expressed by BM sinusoidal endothelial cells (SEC) and the endothelial Tek excision led to BM sinusoidal capillarization. Particularly, the BM sinusoids displayed thinner vessel diameter with the aberrant mural cell coverage in the Tek mutants. Mechanistically, TIE2 insufficiency led to a dramatic decrease of VEGFR3 in BM-SECs while its expression in hepatic sinusoids was not obviously altered. The RNA-seq analysis showed that GO terms enriched for the downregulated genes were related to the biological processes including sinusoidal development while pathways related to arterial ECs and angiogenesis were upregulated in the bone marrow of Tek mutants. The alteration of sinusoidal VEGFR3 expression occurred within 48 h after the induced endothelial deletion of Tek. Consistently, the defective BM sinusoidal formation was validated with the induced Tek deletion in VEGFR3+ SECs. The insufficiency of TIE2 ligand ANGPT1 also led to reduced sinusoidal VEGFR3, accompanied by similar BM sinusoidal defects. Furthermore, disruption of sinusoidal morphogenesis was observed in mutant mice with the endothelial excision of Nr2f2 (COUP-TFII), displaying a decreased expression of BM sinusoidal TIE2 and VEGFR3. These findings suggest that ANGPT1/TIE2 and COUP-TFII form a reciprocal regulatory loop to coordinate BM sinusoidal specification via regulating VEGFR3.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Arteriosclerosis, Thrombosis, and Vascular Biology
65 papers in training set
Top 0.1%
17.2%
2
eLife
5422 papers in training set
Top 4%
12.1%
3
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 0.2%
9.9%
4
Cell Reports
1338 papers in training set
Top 13%
3.9%
5
iScience
1063 papers in training set
Top 5%
3.5%
6
Developmental Cell
168 papers in training set
Top 5%
3.5%
50% of probability mass above
7
Cell Research
49 papers in training set
Top 0.6%
3.0%
8
EMBO reports
136 papers in training set
Top 1%
3.0%
9
Developmental Biology
134 papers in training set
Top 1%
1.9%
10
Development
440 papers in training set
Top 2%
1.8%
11
Genomics, Proteomics & Bioinformatics
171 papers in training set
Top 4%
1.7%
12
Blood Advances
54 papers in training set
Top 0.8%
1.7%
13
PLOS Biology
408 papers in training set
Top 10%
1.7%
14
Nature Communications
4913 papers in training set
Top 53%
1.6%
15
Advanced Science
249 papers in training set
Top 12%
1.6%
16
PLOS ONE
4510 papers in training set
Top 58%
1.3%
17
JCI Insight
241 papers in training set
Top 6%
0.9%
18
Oncogene
76 papers in training set
Top 2%
0.9%
19
Cell Death & Disease
126 papers in training set
Top 2%
0.9%
20
Circulation Research
39 papers in training set
Top 0.9%
0.9%
21
Frontiers in Genetics
197 papers in training set
Top 8%
0.9%
22
Cell Discovery
54 papers in training set
Top 5%
0.8%
23
Journal of Cellular and Molecular Medicine
18 papers in training set
Top 0.9%
0.8%
24
Scientific Reports
3102 papers in training set
Top 73%
0.8%
25
Cells
232 papers in training set
Top 7%
0.7%
26
Blood
67 papers in training set
Top 1%
0.7%
27
The FASEB Journal
175 papers in training set
Top 3%
0.7%
28
Journal of Experimental Medicine
106 papers in training set
Top 4%
0.7%
29
PLOS Genetics
756 papers in training set
Top 16%
0.7%
30
Clinical & Translational Immunology
22 papers in training set
Top 0.3%
0.7%